Clinical Trials Browser

pegamotecan × Clear all

NCT00079950 2012-09-06

Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma

Phase 2 Suspended

Neoplasm Metastasis, Sarcoma

NCT00080002 2012-09-06

Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction

Phase 2 Terminated

Gastrointestinal

Neoplasms, Stomach Neoplasms